- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02148809
Blood Volume Analysis of Total Hip Arthroplasty Patients Under Hypotensive Anesthesia
Hypotensive Anesthesia is a type of regional anesthesia performed routinely at our hospital. This type of anesthesia reduces the average arterial pressure. Benefits include reduced bleeding and lower risk of blood clots.
The purpose of this study is to determine the effect of intravenous fluids administered with hypotensive anesthesia on your blood volume. With this parameter we will be able to understand how much of your blood is lost because of bleeding and how much of the drop is related to dilution.
Study hypothesis: Hemodilution associated with intravenous fluid substitution during hypotensive anesthesia results in decreased postoperative hemoglobin (Hb) levels
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Hospital For Special Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Non- inflammatory degenerative joint disease of the hip
- Patients scheduled for unilateral primary total hip arthroplasty
- Age between 50 and 75 years
- Hypotensive Spinal-epidural anesthesia with systolic BP < 95 and diastolic BP < 65.
- Adequate intraoperative fluid loading: a minimum of 3 L within 6 hours of surgery
Exclusion Criteria:
- Pregnant women or nursing mothers.
- Women of childbearing potential not using adequate birth control methods
- Known hypersensitivity to I-131 albumin or any other component of the Volumex injection kit
- Blood coagulopathies resulting in a hypocoagulable state (hemophilia, von Willebrand disease, etc.)
- Blood coagulopathies resulting in a hypercoagulable state (factor V leiden, antithrombin III deficiency, protein C deficiency, protein S deficiency)
- Patients on anti-coagulants (coumadin, plavix, pradaxa, heparin)
- Congestive Heart Failure (at least one medication to treat congestive heart failure)
- Coronary artery disease (s/p bypass, stent or AMI)
- Kidney insufficiency (creatinine > 1.5)
- Aortic or mitral valve disease
- Pulmonary hypertension
- Revision Hip Surgery
- Inadequate intravenous fluid substitution within the first 6 hrs (<3 liters)
- Inadequate hypotensive anesthesia (mean arterial pressure above 65 for more than 33% of the surgical time
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Blood Volume Analysis, Fluid
Preop I-131 is given and the BVA is performed, 6 hours after surgery the same procedure will be done to compare the TBV at both points
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Total Blood Volume
Time Frame: preoperatively and 6 hours postoperatively
|
The primary outcome is the change in total blood volume (TBV) during the first 6 hours after primary THA utilizing hypotensive anesthesia.
Preoperative TBV will be compared to values 6 hours postoperatively.
|
preoperatively and 6 hours postoperatively
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change IN Plasma Volume PV
Time Frame: preoperative and 6 hours postoperatively
|
An indicator dilution technique was used to measure the blood volume, plasma volume and red cell blood volume. Approved by the Food and Drug Administration in 1998, the BVA-100 blood volume analyzer (Daxor Corp.) is a semi-automated system for blood volume analysis. Prepared standards and injectates were used. The injectate consists of 31I-labeled HSA (370- 1,295 kBq [10-30 mCi]) in saline. Measurement was performed directly before surgery in the holding area and 6 hours after surgery. Each time, before injection of the tracer a baseline sample was taken. After injection of the tracer via standard i.v. line, the first sample was drawn from an arterial line after 12 minutes waiting time. Afterwards every 6 minutes a sample was taken. In a whole 5 samples were sent for analysis to Daxor® Corp.. Each sample is counted in duplicate. |
preoperative and 6 hours postoperatively
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Niemi TT, Pitkanen M, Syrjala M, Rosenberg PH. Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. Acta Anaesthesiol Scand. 2000 Apr;44(4):457-64. doi: 10.1034/j.1399-6576.2000.440418.x.
- Hahn RG. Haemoglobin dilution from epidural-induced hypotension with and without fluid loading. Acta Anaesthesiol Scand. 1992 Apr;36(3):241-4. doi: 10.1111/j.1399-6576.1992.tb03457.x.
- Holte K, Foss NB, Svensen C, Lund C, Madsen JL, Kehlet H. Epidural anesthesia, hypotension, and changes in intravascular volume. Anesthesiology. 2004 Feb;100(2):281-6. doi: 10.1097/00000542-200402000-00016.
- Drobin D, Hahn RG. Time course of increased haemodilution in hypotension induced by extradural anaesthesia. Br J Anaesth. 1996 Aug;77(2):223-6. doi: 10.1093/bja/77.2.223.
- Manzone TA, Dam HQ, Soltis D, Sagar VV. Blood volume analysis: a new technique and new clinical interest reinvigorate a classic study. J Nucl Med Technol. 2007 Jun;35(2):55-63; quiz 77, 79. doi: 10.2967/jnmt.106.035972. Epub 2007 May 11.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB # 13193
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Volume Analysis
-
Shanghai 6th People's HospitalRecruitingMachine Learning | Ultrasound | Blood Volume AnalysisChina
-
PerioCentrum ResearchUnknownImplant Geometry, Osseointegration, Soft Tissue Volume, Marginal Bone Levels, Soft Tissue Recession, Volumetric AnalysisSpain
-
University of California, Los AngelesOlive View-UCLA Education & Research InstituteUnknown
-
University Hospital, LinkoepingCompleted
-
Mahidol UniversityCompleted
-
University Hospital, LinkoepingCompletedBlood Volume, ExtravasationSweden
-
Haydarpasa Numune Training and Research HospitalActive, not recruitingBlood Gas Analysis | Topical AnalgesiaTurkey
-
Cemile Nida KayışCompletedArterial Blood Gas Analysis EducationTurkey (Türkiye)
-
Aalborg UniversityDepartment of Anesthesiology, North Denmark Regional Hospital; Center for Clinical...CompletedEmergency Service, Hospital | Matched-Pair Analysis | Blood Gas Analysis
-
Trinity Western UniversityRecruiting
Clinical Trials on 1mL of I-131 Human Serum Albumin is injected prior to the measurements
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedMantle Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States